Literature DB >> 26493007

3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases.

Maria João Matos1, Fernanda Rodríguez-Enríquez2, Fernanda Borges3, Lourdes Santana4, Eugenio Uriarte4, Martín Estrada5, María Isabel Rodríguez-Franco5, Reyes Laguna2, Dolores Viña6.   

Abstract

Monoamine oxidase (MAO) generates reactive oxygen species (ROS), which cause neuronal cell death, causing neurodegeneration. Agents that are able to concurrently inhibit MAO and scavenge free radicals represent promising multifunctional neuroprotective agents that could be used to delay or slow the progression of neurodegenerative diseases. In this work, variously substituted 3-amidocoumarins are described that exert neuroprotection in vitro against hydrogen peroxide in rat cortical neurons, as well as antioxidant activity in a 1,1-diphenyl-2-picrylhydrazyl (DPPH⋅) radical scavenging assay. Selective and reversible inhibitors of the MAO-B isoform were identified. Interestingly, in the case of the 3-benzamidocoumarins, substitution at position 4 with a hydroxy group abolishes MAO-B activity, but the compounds remain active in the neuroprotection model. Further evaluation of 3-heteroarylamide derivatives indicates that it is the nature of the heterocycle that determines the neuroprotective effects. Evaluation in a parallel artificial membrane permeability assay (PAMPA) highlighted the need to further improve the blood-brain barrier permeability of this compound class. However, the compounds described herein adhere to Lipinski's rule of five, suggesting that this novel scaffold has desirable properties for the development of potential drug candidates.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Parkinson′s disease; coumarin; inhibitors; monoamine oxidase; neuroprotection

Mesh:

Substances:

Year:  2015        PMID: 26493007     DOI: 10.1002/cmdc.201500408

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  5 in total

1.  New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties.

Authors:  Martín Estrada-Valencia; Clara Herrera-Arozamena; Concepción Pérez; Dolores Viña; José A Morales-García; Ana Pérez-Castillo; Eva Ramos; Alejandro Romero; Erik Laurini; Sabrina Pricl; María Isabel Rodríguez-Franco
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin.

Authors:  Marco Mellado; César González; Jaime Mella; Luis F Aguilar; Ismail Celik; Fernanda Borges; Eugenio Uriarte; Giovanna Delogu; Dolores Viña; Maria J Matos
Journal:  Molecules       Date:  2022-01-29       Impact factor: 4.411

3.  Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.

Authors:  Clara Herrera-Arozamena; Martín Estrada-Valencia; Patricia López-Caballero; Concepción Pérez; José A Morales-García; Ana Pérez-Castillo; Eric Del Sastre; Cristina Fernández-Mendívil; Pablo Duarte; Patrycja Michalska; José Lombardía; Sergio Senar; Rafael León; Manuela G López; María Isabel Rodríguez-Franco
Journal:  J Med Chem       Date:  2022-03-04       Impact factor: 7.446

4.  Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent

Authors:  María Del Pilar Olaya; Nadezdha Esperanza Vergel; José Luis López; María Dolores Viña; Mario Francisco Guerrero
Journal:  Biomedica       Date:  2019-09-01       Impact factor: 0.935

Review 5.  Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.

Authors:  Angela Stefanachi; Francesco Leonetti; Leonardo Pisani; Marco Catto; Angelo Carotti
Journal:  Molecules       Date:  2018-01-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.